This potential treatment opportunity was confirmed by the company's bioinformatics platform, PsyCollage
Why now might be a good time to buy gold and gold juniors
Gold has been taking a beating in recent weeks, the sell-off prompted by rising bond yields which are taking the shine off the yellow metal.
Company led by Robert Friedland to invest $44.5M in copper-silver-gold project in Montana
(Kitco News) - Brixton Metals (TSX: BBB, OTCQB: BBBXF) announced today the signing of a USD$44.5 million definitive earn-in agreement with a wholly-owned Montana subsidiary of High Power Exploration (“HPX”), a privately-owned mineral exploration and development company led by Chairman and CEO, Robert Friedland.
First-of-its-kind trial finds psychedelic microdosing is equal to placebo
A first of its kind "self-blinded" trial testing the effect of psychedelic microdosing has found the anecdotally popular practice may be an example of a strong placebo effect.
Texas Voters’ Support For Legalizing Marijuana Is Increasing, New Poll Shows
Texans’ support for legalizing marijuana has grown significantly over the past decade, according to a new poll.
atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round
ATAI announces closing its Series D financing round, raising $157 million.
MINDCURE (CSE: MCUR | OTCQB: MCURF) Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research
The Company expects to have ibogaine manufactured and in use for research by Q4.
Gold edges up as U.S. yields soften
Gold prices inched up on Tuesday, having earlier slid to its lowest in 8-1/2 months, as U.S. Treasury yields eased and offset pressure from a stronger dollar.
MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada's First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin
MINDCURE makes a CAD$500,000 strategic investment in ATMA Journey Centers, an Alberta-based psychedelics-assisted mental health clinic.
MINDCURE (CSE: MCUR | OTCQB MCURF) Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin
The completed equity investment strengthens ties between MINDCURE and ATMA
Biggest Opportunities for Psychedelic Drugs OUTSIDE of Mental Health?
The Mental Health Crisis is a huge opportunity for psychedelic drugs. But the BIGGEST potential markets may exist outside of mental health.
